Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Hospitalized COVID-19
NCT04343755Phase 2Terminated
- Sponsor
- Hackensack Meridian Health
- Start
- Apr 2020
- Primary completion
- Apr 2023
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Hackensack Meridian Health. Primary endpoints: Number of Participants Hospitalized for COVID-19 But Not Intubated at 7 days and Primary Objective for Patients With COVID-19 Already Intubated at 30 days. Started Apr 2020; status: terminated.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04343755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04343755.